Rovazolac
Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.
Product Specifications
CAS Number
1454288-88-0
Product Name Alternative
ALX-101
UNSPSC
12352005
Hazard Statement
H315-H319-H335
Target
LXR
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Rovazolac.html
Purity
99.68
Solubility
Ethanol : 10 mg/mL (ultrasonic)
Smiles
O=C(OCC)CN1C(C2=CC=C(C3=CC(S(C)(=O)=O)=CC=C3)C=C2)=CC(C(F)(F)F)=N1
Molecular Formula
C21H19F3N2O4S
Molecular Weight
452.45
Precautions
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P362+P364-P403+P233-P405-P501
References & Citations
[1]Mohan R. Preparation of substituted pyrazoles as liver X receptor (LXR) modulators useful for the treatment of dermal diseases, disorders and conditions. WO2013130892A1
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
AP02535PU-S 50 µL
GSK3 beta (GSK3B) pTyr216 Rabbit Polyclonal Antibody
Sign In for Pricing
View Details 
